C152H169F14N19O9 — CID 160612251
5-[5-[[4-[(2,6-difluorophenyl)methyl]piperazin-1-yl]methyl]-3-[4-(trifluoromethoxy)phenyl]indol-1-yl]-1-piperidin-2-ylpentan-1-one;3-isocyano-2-[[4-[[1-(5-oxo-5-piperidin-2-ylpentyl)-3-[4-(trifluoromethoxy)phenyl]indol-5-yl]methyl]piperazin-1-yl]methyl]benzonitrile;5-[5-[[4-[(2-methoxyphenyl)methyl]piperazin-1-yl]methyl]-3-[4-(trifluoromethoxy)phenyl]indol-1-yl]-1-piperidin-2-ylpentan-1-one;2-[[4-[[1-(5-oxo-5-piperidin-2-ylpentyl)-3-[4-(trifluoromethoxy)phenyl]indol-5-yl]methyl]piperazin-1-yl]methyl]benzonitrile (PubChem CID 160612251) has the molecular formula C152H169F14N19O9 and a molecular weight of 2672.12 g/mol. Its IUPAC name is 5-[5-[[4-[(2,6-difluorophenyl)methyl]piperazin-1-yl]methyl]-3-[4-(trifluoromethoxy)phenyl]indol-1-yl]-1-piperidin-2-ylpentan-1-one;3-isocyano-2-[[4-[[1-(5-oxo-5-piperidin-2-ylpentyl)-3-[4-(trifluoromethoxy)phenyl]indol-5-yl]methyl]piperazin-1-yl]methyl]benzonitrile;5-[5-[[4-[(2-methoxyphenyl)methyl]piperazin-1-yl]methyl]-3-[4-(trifluoromethoxy)phenyl]indol-1-yl]-1-piperidin-2-ylpentan-1-one;2-[[4-[[1-(5-oxo-5-piperidin-2-ylpentyl)-3-[4-(trifluoromethoxy)phenyl]indol-5-yl]methyl]piperazin-1-yl]methyl]benzonitrile.
| Compound Name | 5-[5-[[4-[(2,6-difluorophenyl)methyl]piperazin-1-yl]methyl]-3-[4-(trifluoromethoxy)phenyl]indol-1-yl]-1-piperidin-2-ylpentan-1-one;3-isocyano-2-[[4-[[1-(5-oxo-5-piperidin-2-ylpentyl)-3-[4-(trifluoromethoxy)phenyl]indol-5-yl]methyl]piperazin-1-yl]methyl]benzonitrile;5-[5-[[4-[(2-methoxyphenyl)methyl]piperazin-1-yl]methyl]-3-[4-(trifluoromethoxy)phenyl]indol-1-yl]-1-piperidin-2-ylpentan-1-one;2-[[4-[[1-(5-oxo-5-piperidin-2-ylpentyl)-3-[4-(trifluoromethoxy)phenyl]indol-5-yl]methyl]piperazin-1-yl]methyl]benzonitrile |
|---|---|
| PubChem CID | 160612251 |
| Molecular Formula | C152H169F14N19O9 |
| Molecular Weight | 2672.12 g/mol |
| Exact Mass | 2670.31 |
| IUPAC Name | 5-[5-[[4-[(2,6-difluorophenyl)methyl]piperazin-1-yl]methyl]-3-[4-(trifluoromethoxy)phenyl]indol-1-yl]-1-piperidin-2-ylpentan-1-one;3-isocyano-2-[[4-[[1-(5-oxo-5-piperidin-2-ylpentyl)-3-[4-(trifluoromethoxy)phenyl]indol-5-yl]methyl]piperazin-1-yl]methyl]benzonitrile;5-[5-[[4-[(2-methoxyphenyl)methyl]piperazin-1-yl]methyl]-3-[4-(trifluoromethoxy)phenyl]indol-1-yl]-1-piperidin-2-ylpentan-1-one;2-[[4-[[1-(5-oxo-5-piperidin-2-ylpentyl)-3-[4-(trifluoromethoxy)phenyl]indol-5-yl]methyl]piperazin-1-yl]methyl]benzonitrile |
| SMILES | COc1ccccc1CN1CCN(Cc2ccc3c(c2)c(-c2ccc(OC(F)(F)F)cc2)cn3CCCCC(=O)C2CCCCN2)CC1.N#Cc1ccccc1CN1CCN(Cc2ccc3c(c2)c(-c2ccc(OC(F)(F)F)cc2)cn3CCCCC(=O)C2CCCCN2)CC1.O=C(CCCCn1cc(-c2ccc(OC(F)(F)F)cc2)c2cc(CN3CCN(Cc4c(F)cccc4F)CC3)ccc21)C1CCCCN1.[C-]#[N+]c1cccc(C#N)c1CN1CCN(Cc2ccc3c(c2)c(-c2ccc(OC(F)(F)F)cc2)cn3CCCCC(=O)C2CCCCN2)CC1 |
| InChI | InChI=1S/C39H41F3N6O2.C38H42F3N5O2.C38H45F3N4O3.C37H41F5N4O2/c1-44-35-9-6-7-30(24-43)34(35)26-47-21-19-46(20-22-47)25-28-11-16-37-32(23-28)33(29-12-14-31(15-13-29)50-39(40,41)42)27-48(37)18-5-3-10-38(49)36-8-2-4-17-45-36;39-38(40,41)48-32-14-12-29(13-15-32)34-27-46(18-6-4-10-37(47)35-9-3-5-17-43-35)36-16-11-28(23-33(34)36)25-44-19-21-45(22-20-44)26-31-8-2-1-7-30(31)24-42;1-47-37-11-3-2-8-30(37)26-44-22-20-43(21-23-44)25-28-12-17-35-32(24-28)33(29-13-15-31(16-14-29)48-38(39,40)41)27-45(35)19-7-5-10-36(46)34-9-4-6-18-42-34;38-32-6-5-7-33(39)31(32)24-45-20-18-44(19-21-45)23-26-10-15-35-29(22-26)30(27-11-13-28(14-12-27)48-37(40,41)42)25-46(35)17-4-2-9-36(47)34-8-1-3-16-43-34/h6-7,9,11-16,23,27,36,45H,2-5,8,10,17-22,25-26H2;1-2,7-8,11-16,23,27,35,43H,3-6,9-10,17-22,25-26H2;2-3,8,11-17,24,27,34,42H,4-7,9-10,18-23,25-26H2,1H3;5-7,10-15,22,25,34,43H,1-4,8-9,16-21,23-24H2 |
| InChIKey | RFQGHNJYIKFEEJ-UHFFFAOYSA-N |
| XLogP | 30.21 |
| TPSA | 260.13 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 27 |
| Rotatable Bonds | 49 |
| Heavy Atoms | 194 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2672.12 |
| LogP ≤ 5 | 30.21 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 27 |
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'} |
|---|